Webinar: Refractory OAB: Tips and Tricks on Optimal 3rd Line Therapy Delivery (2020)

July 23, 2020

Course Director: Kathleen C. Kobashi, MD

Upon completion, participants will be familiar with 3rd line therapies available to treat refractory OAB, including the pros and cons of each option, the current data regarding outcomes to facilitate proper patient counseling, and optimal techniques to maximize the success of the various therapies. The case-based format will provide real-world scenarios by which to learn about the implementation of successful 3rd line options. The course will provide some dedicated focus to tips and tricks regarding the technical aspects of these options and the logistical implementation of them into a busy practice.


Acknowledgments:

The American Urological Association would like to thank the following companies for providing independent educational grants:

  • Astellas
  • Medtronic

Target Audience

  • Urologists
  • Residents
  • Advanced Practice Providers (Nurse Practitioners and Physician Assistants)

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the various 3rd line therapies available to treat refractory OAB and will be able to discuss the pros and cons of each of the 3rd line therapies available to treat refractory OAB.
  2. Explain with the current data regarding outcomes of PTNS, onabotulinumtoxinA, and sacral neuromodulation for treatment of refractory OAB.
  3. Outline how to perform PTNS.
  4. Describe how to perform onabotunlinumtoxinA injections in the office or outpatient setting.
  5. Explain techniques in optimal lead placement for sacral neuromodulation, programming and troubleshooting.


 

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
06/29/2020
Course expires: 
07/23/2023
Event starts: 
07/23/2020 - 8:30pm EDT
Event ends: 
07/23/2020 - 10:00pm EDT
Rating: 
0

Scientific Agenda

Welcome and Introductions

Kathleen Kobashi, MD

Case Discussion

Kathleen Kobashi, MD, Moderator

All Faculty

Questions and Answers

All Faculty

Adjourn

Refractory OAB: Tips and Tricks on Optimal 3rd Line Therapy Delivery (2020) will be held virtually on Thursday, July 23 at 8:30 PM EST.

***Instructions***

  1. Click the "Register" tab.
  2. If prompted, click “update your profile”. Otherwise, click “Take Course”.
  3. Click “Start” under Live Webinar in the Course Progress pane.
  4. Click "Join Webinar".

Education Council Disclosures

PDF icon EC Disclosures _June 1 20 through Dec 31 20_2.pdf

AUA Office of Education Staff has nothing to disclose.

 

Course Director(s)

Kathleen Kobashi, MD,MBA

has a financial relationship (Independent contractor) with Allergan;.
has a financial relationship (Independent contractor) with Medtronic;.
has a financial relationship (Independent contractor) with Contura;.
has a financial relationship (Independent contractor) with Allergan;.
has a financial relationship (Independent contractor) with Medtronic;.
has a financial relationship (Independent contractor) with Contura;.
has a financial relationship (Independent contractor) with Allergan;.
has a financial relationship (Independent contractor) with Medtronic;.
has a financial relationship (Independent contractor) with Contura;.
Faculty(s)

David Ginsberg, MD

has a financial relationship (Other) with Bioness;.
has a financial relationship (Independent contractor) with Axonics;.
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Other) with Bioness;.
has a financial relationship (Independent contractor) with Axonics;.
has a financial relationship (Independent contractor) with Urovant;.
has a financial relationship (Other) with Bioness;.
has a financial relationship (Independent contractor) with Axonics;.
has a financial relationship (Independent contractor) with Urovant;.

Sandip Vasavada

has a financial relationship (Other) with Medtronic;.
has a financial relationship (Independent contractor) with BlueWind;.
has a financial relationship (Independent contractor) with allergan;.
has a financial relationship (Independent contractor) with axonics;.
has a financial relationship (Independent contractor) with astellas;.
has a financial relationship (Independent contractor) with axonics;.
has a financial relationship (Independent contractor) with astellas;.
has a financial relationship (Other) with Medtronic;.
has a financial relationship (Independent contractor) with Amphora;.
has a financial relationship (Stock) with NDI Medical LLC;.
has a financial relationship (Stock) with NDI Medical LLC;.
has a financial relationship (Independent contractor) with axonics;.
has a financial relationship (Independent contractor) with BlueWind;.
has a financial relationship (Independent contractor) with allergan;.
has a financial relationship (Independent contractor) with Amphora;.
has a financial relationship (Independent contractor) with allergan;.
has a financial relationship (Independent contractor) with Amphora;.
has a financial relationship (Stock) with NDI Medical LLC;.
has a financial relationship (Independent contractor) with astellas;.
has a financial relationship (Other) with Medtronic;.
has a financial relationship (Independent contractor) with BlueWind;.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.

To join the webinar:

  1. Click on the TAKE COURSE button.
  2. Click “Start” under Live Webinar in the Course Progress pane.
  3. Click "Join Webinar".